| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | AVTA | Common Stock | Disposed to Issuer | -$3.85M | -148K | -100% | $26.00 | 0 | Nov 27, 2023 | Direct | F1, F2 |
| transaction | AVTA | Common Stock | Award | $0 | +36.2K | $0.00 | 36.2K | Nov 27, 2023 | Direct | F1, F3 | |
| transaction | AVTA | Common Stock | Disposed to Issuer | -$940K | -36.2K | -100% | $26.00 | 0 | Nov 27, 2023 | Direct | F1, F4 |
| transaction | AVTA | Common Stock | Award | $0 | +38K | $0.00 | 38K | Nov 27, 2023 | Direct | F1, F5 | |
| transaction | AVTA | Common Stock | Disposed to Issuer | -$989K | -38K | -100% | $26.00 | 0 | Nov 27, 2023 | Direct | F1, F4 |
| transaction | AVTA | Common Stock | Award | $0 | +24.9K | $0.00 | 24.9K | Nov 27, 2023 | Direct | F1, F6 | |
| transaction | AVTA | Common Stock | Disposed to Issuer | -$648K | -24.9K | -100% | $26.00 | 0 | Nov 27, 2023 | Direct | F1, F4 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | AVTA | Stock Option (Right to Buy) | Disposed to Issuer | -5.98K | -100% | 0 | Nov 27, 2023 | Common Stock | 5.98K | $21.20 | Direct | F1, F7, F8 | ||
| transaction | AVTA | Stock Option (Right to Buy) | Disposed to Issuer | -14.5K | -100% | 0 | Nov 27, 2023 | Common Stock | 14.5K | $22.10 | Direct | F1, F7, F9 | ||
| transaction | AVTA | Stock Option (Right to Buy) | Disposed to Issuer | -27.6K | -100% | 0 | Nov 27, 2023 | Common Stock | 27.6K | $25.24 | Direct | F1, F7, F10 | ||
| transaction | AVTA | Stock Option (Right to Buy) | Disposed to Issuer | -47K | -100% | 0 | Nov 27, 2023 | Common Stock | 47K | $11.30 | Direct | F1, F7, F11 | ||
| transaction | AVTA | Stock Option (Right to Buy) | Disposed to Issuer | -43.3K | -100% | 0 | Nov 27, 2023 | Common Stock | 43.3K | $15.00 | Direct | F1, F7, F12 |
Todd C. Mackay is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.
| Id | Content |
|---|---|
| F1 | Pursuant to the Agreement and Plan of Merger, dated as of September 9, 2023 (as may be amended from time to time, the "Merger Agreement") by and among the Issuer, Aretec Group, Inc., a Delaware corporation ("Parent"), and C2023 Sub Corp., a Delaware corporation and a wholly-owned subsidiary of Parent ("Acquisition Sub"), effective November 27, 2023, among other things, Acquisition Sub merged with and into the Issuer (the "Merger"), with the Issuer surviving as a wholly-owned subsidiary of Parent. |
| F2 | Pursuant to the terms of the Merger Agreement, at the effective time of the Merger (the "Effective Time"), these shares of the Issuer's common stock ("Common Stock") and restricted stock units of the Issuer that vest solely on the basis of time ("RSUs") were automatically canceled and converted into the right to receive an amount in cash, without interest, equal to the product of (i) the reported number of shares multiplied by (ii) $26.00 (less any required tax withholdings). |
| F3 | On January 4, 2021, the reporting person was granted 23,333 performance-based restricted stock units ("PSUs"), which were eligible to vest from 0% to 200% at the end of a three-year performance period based on the Issuer's satisfaction of certain performance criteria. Pursuant to the terms of the Merger Agreement, these PSUs vested prior to the Effective Time at 155% of the target level of performance based on the Company's EBITDA and relative total shareholder return measured over the applicable performance period, as adjusted for the Merger. |
| F4 | Pursuant to the terms of the Merger Agreement, at the Effective Time, these PSUs were automatically canceled and converted into the right to receive an amount in cash, without interest, equal to the product of (i) the number of shares of Common Stock underlying such PSU multiplied by (ii) $26.00 (less any required tax withholdings). |
| F5 | On January 3, 2022, the reporting person was granted 31,702 performance-based restricted stock units ("PSUs"), which were eligible to vest from 0% to 200% at the end of a three-year performance period based on the Issuer's satisfaction of certain performance criteria. Pursuant to the terms of the Merger Agreement, these PSUs vested prior to the Effective Time at 120% of the target level of performance based on the Company's EBITDA and relative total shareholder return measured over the applicable performance period, as adjusted for the Merger. |
| F6 | On January 3, 2023, the reporting person was granted 22,908 performance-based restricted stock units ("PSUs"), which were eligible to vest from 0% to 200% at the end of a three-year performance period based on the Issuer's satisfaction of certain performance criteria. Pursuant to the terms of the Merger Agreement, these PSUs vested prior to the Effective Time at 109% of the target level of performance based on the Company's EBITDA and relative total shareholder return measured over the applicable performance period, as adjusted for the Merger. |
| F7 | Pursuant to the terms of the Merger Agreement, at the Effective Time, these options to purchase shares of Common Stock ("Stock Options") automatically vested (if unvested) and were canceled and converted into the right to receive an amount in cash, without interest, equal to the product of (i) the excess, if any, of $26.00 over the per-share exercise price for such Stock Option multiplied by (ii) the total number of shares of Common Stock underlying such Stock Option, subject to any required tax withholding in accordance with the terms of the Merger Agreement. |
| F8 | The option vested according to the the following vesting schedule: 33.3% of the shares vested on the first anniversary of the grant date and approximately 16.7% vested at the end of each six (6) month period thereafter, such that the option was fully vested on July 1, 2020. |
| F9 | The option vested according to the the following vesting schedule: 33.3% of the shares vested on the first anniversary of the grant date and approximately 16.7% vested at the end of each six (6) month period thereafter, such that the option was fully vested on December 31, 2020. |
| F10 | The option vested equally over a 3-year period, on each anniversary of the grant date, such that the option was fully vested on January 9, 2023. |
| F11 | The option vested equally over a 3-year period, on each anniversary of the grant date, such that the option was fully vested on May 21, 2023. |
| F12 | The option vests equally over a 3-year period, on each anniversary of the grant date, such that the option will fully vest on January 4, 2024. |
Exhibit List: Exhibit 24-Power of Attorney